In comparison with Group 1 (Lp(a) < 270 mg/L and Lp‐PLA2 < 334 ng/mL), the risk of stroke recurrence was 5.766 times higher in Group 2 (Lp(a) ≥ 270 mg/L and Lp‐PLA2 < 334 ng/mL), 6.547 times higher in Group 3 (Lp(a) < 270 mg/L and Lp‐PLA2 ≥ 334 ng/mL), and 14.894 times higher in Group 4 (Lp(a) ≥ 270 mg/L and Lp‐PLA2 ≥ 334 ng/mL), all statistically significant (p < 0.001). Here, PLA2G7 is linked to stroke disorder.